A detailed history of Canaan Partners Xi LLC transactions in Rallybio Corp stock. As of the latest transaction made, Canaan Partners Xi LLC holds 1,910,987 shares of RLYB stock, worth $1.64 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
1,910,987
Previous 2,059,712 7.22%
Holding current value
$1.64 Million
Previous $2.76 Million 19.02%
% of portfolio
2.11%
Previous 3.34%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$1.09 - $1.45 $162,110 - $215,651
-148,725 Reduced 7.22%
1,910,987 $2.24 Million
Q4 2022

Feb 01, 2023

SELL
$4.67 - $14.86 $1.63 Million - $5.2 Million
-350,000 Reduced 14.52%
2,059,712 $13.5 Million
Q4 2021

Feb 03, 2022

BUY
$9.3 - $19.91 $22.4 Million - $48 Million
2,409,712 New
2,409,712 $23 Million

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $27.6M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Canaan Partners Xi LLC Portfolio

Follow Canaan Partners Xi LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canaan Partners Xi LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canaan Partners Xi LLC with notifications on news.